Portage Biotech Inc (PRTG) — Cash Flow-to-Debt Ratio
Portage Biotech Inc (PRTG) has a Cash Flow-to-Debt Ratio of -0.78x as of September 2024, meaning its operating cash flow of $-1.56 Million could theoretically repay -1% of its total liabilities ($2.01 Million) in one year. See Portage Biotech Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Portage Biotech Inc Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Portage Biotech Inc across 27 annual periods. For the full cash flow conversion analysis, see Portage Biotech Inc (PRTG) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Portage Biotech Inc (1998–2025)
Year-by-year debt coverage analysis for Portage Biotech Inc. Check cash flow quality index of Portage Biotech Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.79x | $-5.46 Million | $3.05 Million | ▲ +44.3% |
| 2024 | -3.21x | $-14.30 Million | $4.45 Million | ▼ -531.6% |
| 2023 | -0.51x | $-12.07 Million | $23.73 Million | ▼ -119.8% |
| 2022 | -0.23x | $-6.76 Million | $29.23 Million | ▼ -47.2% |
| 2021 | -0.16x | $-4.28 Million | $27.26 Million | ▼ -16.5% |
| 2020 | -0.13x | $-3.71 Million | $27.53 Million | ▼ -295.5% |
| 2019 | -0.03x | $-858.00K | $25.16 Million | ▲ +98.8% |
| 2018 | -2.79x | $-1.07 Million | $384.00K | ▲ +34.6% |
| 2017 | -4.27x | $-1.32 Million | $309.43K | ▲ +78.1% |
| 2016 | -19.48x | $-5.84 Million | $299.74K | ▼ -362.5% |
| 2015 | -4.21x | $-2.61 Million | $620.56K | ▲ +58.2% |
| 2014 | -10.08x | $-1.94 Million | $191.97K | ▼ -151.5% |
| 2013 | -4.01x | $-1.79 Million | $446.87K | ▼ -696.4% |
| 2012 | -0.50x | $-1.34 Million | $2.66 Million | ▲ +86.9% |
| 2011 | -3.84x | $-2.62 Million | $682.75K | ▼ -3626.2% |
| 2010 | -0.10x | $-356.14K | $3.45 Million | ▲ +95.7% |
| 2009 | -2.39x | $-287.38K | $120.39K | ▲ +70.8% |
| 2008 | -8.18x | $-468.92K | $57.34K | ▲ +25.1% |
| 2007 | -10.93x | $-458.84K | $42.00K | ▼ -139.5% |
| 2006 | -4.56x | $-645.50K | $141.52K | ▼ -837.2% |
| 2004 | -0.49x | $-321.51K | $660.63K | ▲ +22.5% |
| 2003 | -0.63x | $-146.90K | $233.80K | ▲ +49.3% |
| 2002 | -1.24x | $-156.80K | $126.48K | ▲ +66.2% |
| 2001 | -3.67x | $-347.00K | $94.62K | ▼ -19.1% |
| 2000 | -3.08x | $-466.90K | $151.67K | ▲ +41.9% |
| 1999 | -5.30x | $-345.09K | $65.14K | ▼ -522.1% |
| 1998 | -0.85x | $-422.97K | $496.67K | — |